Skip to main content
Top
Published in: European Radiology 9/2010

01-09-2010 | Head and Neck

Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response

Authors: Ann D. King, Frankie K. F. Mo, Kwok-Hung Yu, David K. W. Yeung, Hua Zhou, Kunwar S. Bhatia, Gary M. K. Tse, Alexander C. Vlantis, Jeffrey K. T. Wong, Anil T. Ahuja

Published in: European Radiology | Issue 9/2010

Login to get access

Abstract

Objective

To investigate the role of diffusion-weighted imaging (DWI) in predicting and monitoring chemoradiotherapy response in head and neck squamous cell carcinoma (HNSCC).

Methods

Diffusion-weighted imaging was performed pre-treatment (n = 50), intra-treatment (n = 41) and post-treatment (n = 20). Apparent diffusion coefficient (ADC) values were correlated with locoregional failure (LF).

Results

Locoregional failure occurred in 20/50 (40%) patients. A significant correlation was found between LF and post-treatment ADC (p = 0.02) but not pre- or intra-treatment ADC. Serial change in ADC was even more significant (p = 0.00001), using a fall in ADC early (pre- to intra-treatment) or late (intra- to post-treatment) to indicate LF, achieved 100% specificity, 80% sensitivity and 90% accuracy.

Conclusions

Single ADC measurements pre- or intra-treatment did not predict response, but ADC post-treatment was a marker for LF. Serial change in ADC was an even stronger marker, when using an early or late treatment fall in ADC to identify LF.
Literature
1.
go back to reference McCollum AD, Burrell SC, Haddad RI et al (2004) Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26:890–896CrossRefPubMed McCollum AD, Burrell SC, Haddad RI et al (2004) Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26:890–896CrossRefPubMed
2.
go back to reference Rogers JW, Greven KM, McGuirt WF et al (2004) Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58:694–697PubMed Rogers JW, Greven KM, McGuirt WF et al (2004) Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58:694–697PubMed
3.
go back to reference Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621–630CrossRefPubMed Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621–630CrossRefPubMed
4.
go back to reference Maeda M, Kato H, Sakuma H et al (2005) Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. Am J Neuroradiol 26:1186–1192PubMed Maeda M, Kato H, Sakuma H et al (2005) Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. Am J Neuroradiol 26:1186–1192PubMed
5.
go back to reference Sumi M, Sakihama N, Sumi T et al (2003) Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 24:1627–1634PubMed Sumi M, Sakihama N, Sumi T et al (2003) Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 24:1627–1634PubMed
6.
go back to reference Habermann CR, Gossrau P, Graessner J et al (2005) Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 177:940–945PubMed Habermann CR, Gossrau P, Graessner J et al (2005) Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 177:940–945PubMed
7.
go back to reference King AD, Ahuja AT, Yeung DKW et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of MR diffusion weighted imaging (DWI). Radiology 245:806–813CrossRefPubMed King AD, Ahuja AT, Yeung DKW et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of MR diffusion weighted imaging (DWI). Radiology 245:806–813CrossRefPubMed
8.
go back to reference Vandecaveye V, De Keyzer F, Vander Poortan V et al (2009) Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 251:134–146CrossRefPubMed Vandecaveye V, De Keyzer F, Vander Poortan V et al (2009) Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 251:134–146CrossRefPubMed
9.
go back to reference de Bondt RB, Hoeberigs MC, Nelemans PJ et al (2009) Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 51:183–192CrossRefPubMed de Bondt RB, Hoeberigs MC, Nelemans PJ et al (2009) Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 51:183–192CrossRefPubMed
10.
go back to reference Holzapfel K, Duetsch S, Fauser C et al (2009) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 72:381–387CrossRefPubMed Holzapfel K, Duetsch S, Fauser C et al (2009) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 72:381–387CrossRefPubMed
11.
go back to reference Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986–994CrossRefPubMed Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986–994CrossRefPubMed
12.
go back to reference Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971PubMed Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971PubMed
13.
go back to reference Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed
14.
15.
go back to reference Van der Brekel MWM, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379–384PubMed Van der Brekel MWM, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379–384PubMed
16.
go back to reference Chenevert TL, Stegman LD, Taylor JM et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92:2029–2036CrossRefPubMed Chenevert TL, Stegman LD, Taylor JM et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92:2029–2036CrossRefPubMed
17.
go back to reference Pickles MD, Gibbs Peter, Lowry M et al (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843–847 Pickles MD, Gibbs Peter, Lowry M et al (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843–847
18.
go back to reference Moffat BA, Chenevert TL, Meyer CR et al (2006) The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 8:259–267CrossRefPubMed Moffat BA, Chenevert TL, Meyer CR et al (2006) The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 8:259–267CrossRefPubMed
19.
go back to reference Mardor Y, Pfeffer R, Spiegelmann R et al (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094–1100CrossRefPubMed Mardor Y, Pfeffer R, Spiegelmann R et al (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094–1100CrossRefPubMed
20.
go back to reference Sharma U, Danishad KK, Seenu V et al (2009) Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 22:104–103CrossRefPubMed Sharma U, Danishad KK, Seenu V et al (2009) Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 22:104–103CrossRefPubMed
21.
go back to reference Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831–837CrossRefPubMed Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831–837CrossRefPubMed
22.
go back to reference Zhao M, Pipe JG, Bonnett J et al (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73:61–64PubMed Zhao M, Pipe JG, Bonnett J et al (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73:61–64PubMed
23.
go back to reference Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7:779–787CrossRefPubMed Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7:779–787CrossRefPubMed
24.
go back to reference Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3:1457–1466PubMed Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3:1457–1466PubMed
25.
go back to reference Lee KC, Hall DE, Hoff BA et al (2006) Dynamic imaging of emerging resistance during cancer therapy. Cancer Res 66:4687–4692CrossRefPubMed Lee KC, Hall DE, Hoff BA et al (2006) Dynamic imaging of emerging resistance during cancer therapy. Cancer Res 66:4687–4692CrossRefPubMed
Metadata
Title
Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response
Authors
Ann D. King
Frankie K. F. Mo
Kwok-Hung Yu
David K. W. Yeung
Hua Zhou
Kunwar S. Bhatia
Gary M. K. Tse
Alexander C. Vlantis
Jeffrey K. T. Wong
Anil T. Ahuja
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
European Radiology / Issue 9/2010
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1769-8

Other articles of this Issue 9/2010

European Radiology 9/2010 Go to the issue